A patient on insulin glargine (Lantus) 20 units at bedtime has fasting glucose ~220 mg/dL each morning; how many additional units should the bedtime dose be increased?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Increase Lantus by 4 Units Every 3 Days Until Fasting Glucose Reaches Target

For a patient on Lantus 20 units at bedtime with persistent morning fasting glucose around 220 mg/dL, increase the dose by 4 units every 3 days until fasting glucose consistently reaches 80–130 mg/dL. 1

Immediate Dose Adjustment

  • Increase Lantus from 20 units to 24 units tonight, then continue systematic titration every 3 days based on fasting glucose patterns 1
  • The current dose of 20 units is profoundly inadequate for a fasting glucose of 220 mg/dL, requiring aggressive escalation 1

Evidence-Based Titration Algorithm

Standard Protocol

  • Increase by 4 units every 3 days when fasting glucose is ≥180 mg/dL (as in this case with 220 mg/dL) 1
  • Increase by 2 units every 3 days when fasting glucose is 140–179 mg/dL 1
  • Target fasting glucose: 80–130 mg/dL 1

Expected Trajectory

  • Starting at 20 units with fasting glucose 220 mg/dL, expect to reach approximately 32–40 units within 2–3 weeks of systematic titration 1, 2
  • Each 4-unit increment typically lowers fasting glucose by approximately 30–50 mg/dL, though individual response varies 1

Daily Monitoring Requirements

  • Check fasting glucose every morning during titration to guide dose adjustments 1, 3
  • Record all fasting values to identify patterns over each 3-day period 1
  • If any fasting glucose falls <70 mg/dL, immediately reduce the dose by 10–20% and treat with 15 g fast-acting carbohydrate 1

Critical Threshold: When to Stop Basal Escalation

  • Cease further Lantus increases when the dose approaches 0.5–1.0 units/kg/day without achieving fasting glucose targets 1
  • At this threshold, add prandial (mealtime) insulin rather than continuing basal escalation to avoid "over-basalization" 1
  • Clinical signals requiring prandial insulin addition include:
    • Basal dose >0.5 units/kg/day
    • Bedtime-to-morning glucose differential ≥50 mg/dL
    • Episodes of hypoglycemia despite overall hyperglycemia
    • High glucose variability throughout the day 1

Timing Flexibility

  • Lantus can be administered at bedtime, in the morning, or at any consistent time without significant difference in efficacy 4, 5, 6
  • Morning administration may reduce nocturnal hypoglycemia risk compared to bedtime dosing 3, 5
  • The key is consistency—administer at the same time each day 1, 3

Foundation Therapy Optimization

  • Continue metformin at maximum tolerated dose (up to 2000–2550 mg daily) when intensifying Lantus, as this combination reduces total insulin requirements by 20–30% 1
  • Metformin should never be discontinued when adding or intensifying insulin unless specifically contraindicated 1

Expected Clinical Outcomes

  • With systematic 4-unit increments every 3 days, most patients achieve fasting glucose 80–130 mg/dL within 2–4 weeks 1, 2
  • This aggressive titration approach yields HbA1c reductions of 1.5–2.0% over 3–6 months 1
  • Properly implemented basal insulin titration does not increase hypoglycemia incidence when dose adjustments follow the protocol 1

Common Pitfalls to Avoid

  • Do not delay dose escalation when fasting glucose consistently exceeds 180 mg/dL; prolonged hyperglycemia increases complication risk 1
  • Do not use 2-unit increments for fasting glucose ≥180 mg/dL—this under-doses and prolongs time to target 1
  • Do not continue escalating Lantus beyond 0.5–1.0 units/kg/day without addressing postprandial hyperglycemia with prandial insulin 1
  • Never rely solely on correction (sliding-scale) insulin without adequate basal coverage; this reactive approach is condemned by major diabetes guidelines 1

Patient Self-Titration Empowerment

  • Equip the patient with a self-titration algorithm to adjust their own Lantus dose based on fasting glucose readings 1, 2
  • Patient-managed titration (increasing by 2 units every 3 days when fasting glucose remains above target) achieves greater HbA1c reductions than clinic-managed titration alone 2
  • Provide clear written instructions: "If your average fasting glucose over 3 days is ≥180 mg/dL, increase your Lantus by 4 units; if 140–179 mg/dL, increase by 2 units" 1, 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.